Viatris- Theramex deal for women's care products raises antitrust concerns in U.K. Apr. 04, 2024 8:55 AM ET By: Dulan Lokuwithana , SA News Editor [Seeking Alpha]
Viatris Inc. (VTRS)
Company Research
Source: Seeking Alpha
divest the European rights to its women's healthcare products, Duphaston and Femoston, to Theramex. Duphaston and Femoston, which comprise progesterone and estrogen receptor agonists, are prescribed as hormone replacement therapy (HRT) to help relieve menopause symptoms. Following a Phase 1 probe, the U.K.'s Competition and Markets Authority (CMA) said the deal would likely hurt competition in the HRT market. Theramex already dominates the U.K.'s HRT market with its oestrogen patches and combined oestrogen and progestogen patches and pills. "The reduction of HRT alternatives in a market that is already highly concentrated could reduce choice and also lead to potential price increases, as well as raising concerns about the security of supply," the CMA said. The companies will have five working days to respond before the regulator starts an in-depth Phase 2 investigation into the deal. The transaction was part of a series of $3.6B divestitures that Pfizer ( PFE ) spinoff Viatr
Show less
Read more
Impact Snapshot
Event Time:
VTRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTRS alerts
High impacting Viatris Inc. news events
Weekly update
A roundup of the hottest topics
VTRS
News
- Viatris to Participate in the BofA Securities 2024 Health Care Conference [Yahoo! Finance]Yahoo! Finance
- Viatris to Participate in the BofA Securities 2024 Health Care ConferencePR Newswire
- NeurologyLive® and CMSC Announce the 3rd Annual Class of Inductees [Yahoo! Finance]Yahoo! Finance
- Viatris Expands its Wellbeing Program with the Launch of Unmind, a Leading Workplace Resource Focused on Mental Health [Yahoo! Finance]Yahoo! Finance
- Viatris Expands its Wellbeing Program with the Launch of Unmind, a Leading Workplace Resource Focused on Mental HealthPR Newswire
VTRS
Earnings
- 2/28/24 - Miss
VTRS
Sec Filings
- 4/26/24 - Form 10-K/A
- 4/19/24 - Form 4
- 4/19/24 - Form 3
- VTRS's page on the SEC website